Advances in molecular staging of melanoma patients: Multimarker analysis of archival lymph node tissue

Journal of Clinical Oncology

Volumn 21, Issue 19, 2003, Pages 3550-3551

  Busam, Klaus J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2; DIFFERENTIATION ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; EDITORIAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE; LYMPH NODE BIOPSY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; IMMUNOLOGY; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; METHODOLOGY; NOTE; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

ANTIGENS, DIFFERENTIATION; ANTIGENS, NEOPLASM; HUMANS; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SPECIMEN HANDLING; TUMOR MARKERS, BIOLOGICAL;

EID: 0141904696     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.07.982     Document Type: Editorial

References (11)

1. Ferrone CR, Panageas KS, Busam K, et al: Multivariate prognostic model for patients with thick cutaneous melanoma: Importance of sentinel lymph node status. Ann Surg Oncol 9:637-645, 2002
2. Morton DL, Wen D, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
3. Balch CM, Buzaid AC, Soong SJ, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635-3648, 2001
4. McMasters KM, Reintgen DS, Ross MI, et al: Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement. J Clin Oncol 19:2851-2855, 2001
5. Shivers SC, Wang X, Li W, et al: Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 280:1410-1415, 1998
6. Bieligk SC, Ghossein R, Bhattacharya S, et al: Detection of tyrosinase mRNA by reverse transcriptase polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 6:232-240, 1999
7. Ribuffo D, Gradilone A, Vonella M, et al: Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol 10:396-402, 2003
8. McMasters KM: Molecular staging of melanoma: Sensitivity, specificity, and the search for clinical significance. Ann Surg Oncol 10:336-337, 2003
9. Bonin S, Niccolini B, Calacione R, et al: Molecular analysis of sentinel lymph nodes: An open question. J Eur Acad Dermatol Venereol 16:34-39, 2002
10. Kuo CT, Hoon DSB, Takeuchi H, et al: Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol 21:3566-3572, 2003
11. Carson KF, Wen DR, Li PX, et al: Nodal nevi and cutaneous melanomas. Am J Surg Pathol 20:834-840, 1996